日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interactions of Amphiphilic Janus Nanoparticles with Lipid Monolayers

两亲性 Janus 纳米粒子与脂质单层的相互作用

Santo, Kolattukudy P; Min, Younjin; Neimark, Alexander V

Protocol for testing global neuronal workspace and integrated information theories of consciousness in non-human primates and mice

用于测试非人灵长类动物和小鼠的全局神经元工作空间和意识整合信息理论的方案

Gibbons, Matilda; McBride, Ethan G; Holenarasipura Venkatasubbaiah, Raghuram; Khalili-Ardali, Majid; Kuyat, Jacqulyn R; Gale, Samuel; LaFehr, Vayle; Vogler, Nathan W; Kheirkhah Ravandi, Mohammadali; Tsai, Ming-Jiun; Bennett, Corbett; Sridhar, Arjun; Hardcastle, Benjamin; Cabasco, Hannah; Koch, Christof; Naccache, Lionel; Tononi, Giulio; Olsen, Shawn; Neimark Geffen, Maria; Panagiotaropoulos, Theofanis I; Saalmann, Yuri B

Phase Transformations in MOFs Induced by Adsorbate Exchange

吸附质交换诱导金属有机框架(MOF)相变

Neimark, Alexander V; Corrente, Nicholas J; Coudert, François-Xavier

Risankizumab in Japanese patients with moderate-to-severe palmoplantar pustulosis: Results from the randomized, phase 3 JumPPP study

Risankizumab治疗日本中重度掌跖脓疱病患者:来自随机3期JumPPP研究的结果

Okubo, Yukari; Murakami, Masamoto; Kobayashi, Satomi; Tsuji, Shigeyoshi; Kishimoto, Mitsumasa; Ikeda, Kimitoshi; Jibiki, Maiko; Neimark, Ezequiel; Padilla, Byron; Shen, Jie; Peters, Sydney; Terui, Tadashi

Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.

Risankizumab治疗溃疡性结肠炎:两项随机临床试验

Louis Edouard, Schreiber Stefan, Panaccione Remo, Bossuyt Peter, Biedermann Luc, Colombel Jean-Frederic, Parkes Gareth, Peyrin-Biroulet Laurent, D'Haens Geert, Hisamatsu Tadakazu, Siegmund Britta, Wu Kaichun, Boland Brigid S, Melmed Gil Y, Armuzzi Alessandro, Levine Phillip, Kalabic Jasmina, Chen Su, Cheng Ling, Shu Lei, Duan W Rachel, Pivorunas Valerie, Sanchez Gonzalez Yuri, D'Cunha Ronilda, Neimark Ezequiel, Wallace Kori, Atreya Raja, Ferrante Marc, Loftus Edward V Jr

Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial

在一项随机3期试验中,Risankizumab维持治疗可维持克罗恩病患者的诱导反应。

Ferrante, Marc; Irving, Peter M; Abreu, Maria T; Axler, Jeffrey; Gao, Xiang; Cao, Qian; Fujii, Toshimitsu; Rausch, Astrid; Torres, Joana; Neimark, Ezequiel; Song, Alexandra; Wallace, Kori; Kligys, Kristina; Berg, Sofie; Liao, Xiaomei; Zhou, Qing; Kalabic, Jasmina; Feagan, Brian; Panaccione, Remo

Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease

克罗恩病症状严重程度(CSS)问卷在中重度活动性克罗恩病患者中的内容效度和心理测量学评价

Louis, Edouard; Lee, Wan-Ju; Litcher-Kelly, Leighann; Ollis, Sarah; Pranschke, Emma; Fitzgerald, Kristina; Lacerda, Ana Paula; Neimark, Ezequiel; Sanchez Gonzalez, Yuri; Panés, Julian

Adsorption of pulmonary and exogeneous surfactants on SARS-CoV-2 spike protein

肺表面活性物质和外源性表面活性物质在SARS-CoV-2刺突蛋白上的吸附

Santo, Kolattukudy P; Neimark, Alexander V

Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's Disease

使用体外注射器给药的利沙珠单抗治疗中重度克罗恩病的疗效、安全性、患者体验和耐受性

Loftus, Edward V Jr; Griffith, Jenny; Neimark, Ezequiel; Song, Alexandra; Wallace, Kori; Nannapaneni, Sujani; Zhou, Ji; Byrne, Rachel; Kligys, Kristina; Pang, Yinuo; Liao, Xiaomei; Kalabic, Jasmina; Dubinsky, Marla

Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease

匹配调整后的间接比较:Risankizumab 与 Ustekinumab 用于中重度活动性克罗恩病诱导和维持治疗的疗效

Dubinsky, Marla; Ma, Christopher; Griffith, Jenny; Crowell, Marjorie; Neimark, Ezequiel; Kligys, Kristina; O'Connell, Tom